This compound is a pharmaceutical intermediate used in the manufacturing of trilaciclib. It features a tert-butyl carbamate group linked to a cyclohexylamine moiety bearing a bromo-chloropyrimidine substituent.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
7-(1-(((Tert-butoxycarbonyl)amino)methyl)cyclohexyl)-2-chloro-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid
pharmaceutical intermediate
Trilaciclib Impurity 36
pharmaceutical intermediate
(2-chloro-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)methanol
pharmaceutical intermediate
Tert-butyl 4-(6-((7-cyclopentyl-6-(dimethylcarbamoyl)-7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate
pharmaceutical intermediate
TERT-BUTYL (2R,3R)-3-AMINO-2-METHYLPYRROLIDINE-1-CARBOXYLATE
pharmaceutical intermediate
tert-butyl N-[[1-[(5-bromo-2-chloropyrimidin-4-yl)amino]cyclohexyl]methyl]carbamate
GPCHFSKUUKKXAN-UHFFFAOYSA-N
CC(C)(C)OC(=O)NCC1(CCCCC1)NC2=NC(=NC=C2Br)Cl
—
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.